Although previous work has suggested a possible inverse association between Se levels and risk of prostate cancer [4], studies of the influence of genetic variants in selenoprotein genes on prostate cancer risk or survival have been limited [13], [17], [18]. This evidence concerns the gene SELENOS and prostate carcinoma.